Check out Figure 2 below to see the names of specific GLP-1 RA medications and what theyre approved to treat
Increasing payer support and reimbursement coverage, enabling broader patient access and long-term market growth Government Initiatives Supporting the Obesity GLP-1 Market As obesity is increasingly recognized as a chronic, high-burden disease, government initiatives are playing a key role in supporting the obesity GLP-1 market
This helps keep your blood sugar from climbing too high
It exerts a strong hypoglycaemic effect by potentiating insulin secretion in beta cells [5] and inhibiting glucagon secretion in alpha cells [6]
8 If rapid and dramatic glycemic control on GLP-1RAs is the underlying mechanism of the association with DR, this phenomenon has already been described in the literature in association with insulin use
Instead, we took advantage of three amino acid substitutions (E505Q, T527M, and K573P